PER
Click for more information
4.65% 9.0¢ percheron therapeutics limited

Where others have failed will Atl1102 succeed ?, page-200

  1. Popeye82
    22,358 Posts.
    lightbulb Created with Sketch. 485
    clock Created with Sketch.
    02/06/21
    09:19
    Post #: 53582010

    US FDA Feedback on Type C Meeting for ATL1102 in the US

    - Clarity on path forward for a Phase IIb/III including the potential exploration of higher doses
    - Company to submit Fast Track Designation Request based on FDA feedback
    http://www.antisense.com.au/wp-content/uploads/2021/06/ASX-21_-1-June_ATL1102-FDA-Type-C-meeting.pdf
    ANP Price at posting: 19.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 9  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS TRENDING: High grade drilling assays
right-arrow Created with Sketch.
NEWS $2.2M Placement to Expand Resources and Continue Exploration
right-arrow Created with Sketch.
NEWS Rock Chip results up to 170g/t Au on Komboro at Napie
right-arrow Created with Sketch.
NEWS Week 37 Wrap: HotCopper likes Cuban oil; markets shrug debate off for Putin; firebrand quant says social media a market threat
right-arrow Created with Sketch.
NEWS A$17 Million Cash Sale of Citadel Joint Venture Interest
right-arrow Created with Sketch.
NEWS US fracking support boosts outlook for Australian gas stocks
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
9.0¢ 		Change
0.004(4.65%) 		Mkt cap ! $81.13M
Open High Low Value Volume
8.6¢ 9.1¢ 8.5¢ $181.6K 2.049M

Buyers (Bids)

No. Vol. Price($)
1 10344 8.7¢
 

Sellers (Offers)

Price($) Vol. No.
9.0¢ 64275 1
View Market Depth
Last trade - 16.10pm 13/09/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.